ContractIndividual Clinical Trial Agreement • June 24th, 2024
INDIVIDUAL CLINICAL TRIAL AGREEMENTInstitution 1293.13 SMLOUVA O KONKRÉTNÍM KLINICKÉM HODNOCENÍZdravotnické Zařízení 1293.13 This Individual Clinical Trial Agreement (“ICTA”) is entered into on the last date of signature below and shall be effective not earlier than the day of its publication in the Contract Register (the “Effective Date of the ICTA”) by and among Institution: Institute of Rheumatology Address: Na Slupi 4128 50 Prague 2 Czech RepublicTaxpayer ID No.: CZ00023728(hereinafter referred to as “Institution”) and Sponsor: Boehringer Ingelheim RCVGmbH & Co KGAddress: Dr. Boehringer-Gasse 5-111121 Vienna AustriaVAT-ID-No.: ATU 64226215(hereinafter referred to as “Sponsor”) (hereinafter jointly referred to as “the Parties”) Tato Smlouva o konkrétním klinickém hodnocení (dále jen „SKKH“) se uzavírá ke dni jejího podpisu poslední smluvní stranou a nabývá účinnosti nejdříve dne zveřejnění v registru smluv (dále jen „Den účinnosti SKKH“) mezi těmito smluvními stranami: Zdravotnickéz
ContractIndividual Clinical Trial Agreement • July 27th, 2017
INDIVIDUAL CLINICAL TRIAL AGREEMENT This Individual Clinical Trial Agreement (“ICTA”) is entered into on the last date of signature below (the “Effective Date”) by and among Institution: University hospital Brno Address: Jihlavská 20625 00 Brno Taxpayer ID No.: CZ 65269705 Acting through: MUDr. Roman Kraus, MBA - director(hereinafter referred to as “Institution”) and Sponsor: Boehringer Ingelheim RCV GmbH & Co KGAddress: Dr. Boehringer-Gasse 5-11 1121 ViennaAustriaVAT-ID-No.: ATU 64226215(hereinafter referred to as “Sponsor”) (hereinafter jointly referred to as “the Parties”) RECITALSWhereas, BI RCV and Institution entered into a Master Clinical Trial Agreement (“Agreement”) effective on 18. 11. 2013; Whereas, pursuant to Section 2 of the Agreement, BI RCV and Institution wish to enter into this ICTA for the purpose of setting forth the Protocol Number, Protocol Title and specific terms and conditions for the conduct of an individual clinical trial.Now, therefore, pursuant to and subje
ContractIndividual Clinical Trial Agreement • January 18th, 2017
AMENDMENT NO. 1to the Individual Clinical Trial Agreement for BI Trial No. 1199.93,dated as of 28 June 2016 (“Agreement”) DODATEK č. 1ke Smlouvě o konkrétním klinickém hodnocenípro Klinickou studii BI 1199.93 uzavřenou dne 28.06.2016(“Smlouva”) by and between Boehringer Ingelheim RCV GmbH & Co KGDr. Boehringer-Gasse 5-11,1121 Vienna, AustriaVAT-ID-No.: ATU 64226215(hereinafter referred to as "Sponsor") Uzavřena mezi Boehringer Ingelheim RCV GmbH & Co KGDr. Boehringer-Gasse 5-11,1121 Vienna, AustriaDIČ: ATU 64226215(dale jen „Zadavatel”) and FN Olomouc, Klinika nemoci plicních a TBCI.P. Pavlova 6, 779 20 OlomoucTaxpayer ID No.: CZ00098892 IC: 00098892(hereinafter referred to as "Institution") a FN Olomouc, Klinika nemoci plicních a TBCI.P. Pavlova 6, 77920 Olomouc DIČ: CZ00098892 IC: 00098892(dále jen „Zdravotnické zařízení“) WHEREAS, Sponsor and Institution have entered into the Agreement. WHEREAS, Sponsor and Institution desire to continue the successful relationship by altering the A
BI Contract No. / Smlouva BI č.: 232197Individual Clinical Trial Agreement • December 15th, 2016
INDIVIDUAL CLINICAL TRIAL AGREEMENT - INSTITUTION SMLOUVA O KONKRÉTNÍM KLINICKÉM HODNOCENÍ – ZDRAVOTNICKÉ ZAŘÍZENÍ This Individual Clinical Trial Agreement (“ICTA”) is entered into on the last date of signature below (the “Effective Date of the ICTA”) by and among Institution: General University HospitalPrague Address: U nemocnice 499/2 128 08 Prague 2 Czech RepublicTaxpayer ID No.: CZ00064165(hereinafter referred to as “Institution”) and Sponsor: Boehringer Ingelheim RCVGmbH & Co KGAddress: Dr. Boehringer-Gasse 5-11 1121 ViennaAustriaVAT-ID-No.: ATU 64226215(hereinafter referred to as “Sponsor”) (hereinafter jointly referred to as “the Parties”) Tato Smlouva o konkrétním klinickém hodnocení (dále jen „SKKH“) se uzavírá ke dni jejího podpisu poslední smluvní stranou (dále jen „Den účinnosti SKKH“) mezi těmito smluvními stranami: Zdravotnickézařízení: Všeobecná fakultní nemocnice v PrazeAdresa: U nemocnice 499/2128 08 Praha 2 Česká republikaDIČ: CZ00064165(dále jen „Zdravotnické zařízen
ContractIndividual Clinical Trial Agreement • December 17th, 2023
INDIVIDUAL CLINICAL TRIAL AGREEMENT SMLOUVA O KONKRÉTNÍM KLINICKÉM HODNOCENÍ This Individual Clinical Trial Agreement (hereinafter “ICTA”) is made by and among: Institution: Fakultní nemocnice BulovkaAddress: Budínova 67/2, 180 81 Prague 8, Czech RepublicTaxpayer ID/No.: CZ00064211/00064211 Represented by MUDr. Lívia Večeřová, Ph.D., MBA, Deputy of Science, Research, Grant Activities and Development, based on authorization (hereinafter referred to as “Institution”) andSponsor: Boehringer Ingelheim RCV GmbH & Co KGAddress: Dr. Boehringer-Gasse 5-11 1121 ViennaAustriaVAT-ID-No.: ATU 64226215(hereinafter referred to as “Sponsor” or “BI”) represented byIQVIA RDS Eastern Holding GmbH,Stella-Klein-Low-Weg 15 Rund 4, Haus B, 1020 Vienna, Austria, based on the Letter of Authorization for BI Trial 1368-0098 datedXXX. (hereinafter jointly referred to as “the Parties”) Tato Smlouva o konkrétním klinickém hodnocení (dále jen „SKKH“) se uzavírá mezi těmito smluvními stranami: Zdravotnickézařízení:
ContractIndividual Clinical Trial Agreement • October 7th, 2021
INDIVIDUAL CLINICAL TRIAL AGREEMENT - INSTITUTION SMLOUVA O KONKRÉTNÍM KLINICKÉM HODNOCENÍ – ZDRAVOTNICKÉ ZAŘÍZENÍ This Individual Clinical Trial Agreement (“ICTA”) is entered into on the last date of signature below (the “Validity Date of the ICTA”) with effective date of its publication in the Contract Register (the “Effective Date of the ICTA) by and among Institution:Všeobecná fakultní nemocnice v PrazeAddress: U Nemocnice 499/2128 08 Prague 2 Czech RepublicTaxpayer ID No.: CZ00064165 (hereinafter the “Institution”) and Sponsor: Boehringer Ingelheim RCV GmbH & Co KGAddress: Dr. Boehringer-Gasse 5-11 1121 ViennaAustriaVAT-ID-No.: ATU 64226215(hereinafter referred to as “Sponsor”) (hereinafter jointly referred to as “the Parties”) Tato Smlouva o konkrétním klinickém hodnocení (dále jen „SKKH“) se uzavírá ke dni jejího podpisu poslední smluvní stranou (dále jen „Den platnosti SKKH“) s účinností ke dni uveřejnění v registru smluv (dále jen „Den účinnosti SKKH“) mezi těmito smluvními st
